Literature DB >> 12775624

How can research ethics committees protect patients better?

Silvio Garattini1, Vittorio Bertele, Luca Li Bassi.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh：

Substances：

Year:  2003        PMID： 12775624      PMCID： PMC1126056          DOI： 10.1136/bmj.326.7400.1199

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  23 in total

1.  Learning from the cerivastatin experience.

Authors:  J A Farmer
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

2.  Placebo-controlled trials and the Declaration of Helsinki.

Authors:  John A Lewis; Bertil Jonsson; Gottfried Kreutz; Cristina Sampaio; Barbara van Zwieten-Boot
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

3.  Inconclusive messages from equivalence trials in thrombolysis.

Authors:  V Bertele; V Torri; S Garattini
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

4.  Does placebo help establish equivalence in trials of new antidepressants?

Authors:  C Barbui; A Violante; S Garattini
Journal:  Eur Psychiatry       Date:  2000-06       Impact factor: 5.361

Review 5.  Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.

Authors:  J Geddes; N Freemantle; P Harrison; P Bebbington
Journal:  BMJ       Date:  2000-12-02

Review 6.  Body weight changes associated with psychopharmacology.

Authors:  Yelena Vanina; Anna Podolskaya; Karim Sedky; Hasan Shahab; Abufarah Siddiqui; Firoz Munshi; Steven Lippmann
Journal:  Psychiatr Serv       Date:  2002-07       Impact factor: 3.084

7.  Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study.

Authors:  Raimund Margreiter
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

Review 8.  Treatment of suicidality in schizophrenia.

Authors:  H Y Meltzer
Journal:  Ann N Y Acad Sci       Date:  2001-04       Impact factor: 5.691

9.  Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate.

Authors:  K R Fontaine; M Heo; E P Harrigan; C L Shear; M Lakshminarayanan; D E Casey; D B Allison
Journal:  Psychiatry Res       Date:  2001-04-15       Impact factor: 3.222

10.  Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.

Authors:  R Temple; S S Ellenberg
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391
View more
  5 in total

1.  No more free lunches.

Authors:  Kamran Abbasi; Richard Smith
Journal:  BMJ       Date:  2003-05-31

Review 2.  How can we regulate medicines better?

Authors:  Silvio Garattini; Vittorio Bertele'
Journal:  BMJ       Date:  2007-10-20

Review 3.  [Ethical implications of placebo-controlled clinical trials for psychotropic drugs].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2005-11       Impact factor: 1.214

4.  Ethical issues in naturalistic versus controlled trials.

Authors:  Hanfried Helmchen
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

Review 5.  Ability of a meta-analysis to prevent redundant research: systematic review of studies on pain from propofol injection.

Authors:  Céline Habre; Martin R Tramèr; Daniel M Pöpping; Nadia Elia
Journal:  BMJ       Date:  2014-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.